Kinga Bernatowicz, PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, comments on the findings from a study assessing multiparametric MRI (mpMRI) predicting response to immunotherapy (IO) in patients with solid tumors. Different signals such as vasculature were able to be used as predictors of response, and machine learning tools additionally enabled the stratification of patients. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.